Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer

NCT03203304 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Study stopped due to poor accrual.

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

University of Chicago